CClinicalTrials.gg
CompletedNCT02601521PiHQUpdated Feb 24, 2021

Comparative Effectiveness of Two Tobacco Cessation Interventions for Employees of Partners HealthCare, Inc.

An interventional study of Internal tobacco coach and External tobacco coach in Smoking Cessation and Tobacco Use Disorder, sponsored by Massachusetts General Hospital. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-02-24.

Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
106
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Specific Aim: To conduct a randomized controlled trial among permanent employees of Partners HealthCare, Inc., and their adult dependents, who are current tobacco smokers. The trial will compare two interventions designed to help smokers stop using tobacco: (1) External Coaching Program (Standard Care) and (2) Internal Coaching Program, a chronic disease management strategy for treating tobacco use and dependence.

02

Conditions studied

  • Smoking Cessation
  • Tobacco Use Disorder

Browse trials for

03

In context

Tobacco Use Disorder

968 studies on the registry are indexed under Tobacco Use Disorder; 127 are open to participants now.

This study's enrollment of 106 is above the median of 90 across 851 interventional studies indexed under Tobacco Use Disorder.

Browse Tobacco Use Disorder studies →

Lead sponsor

Massachusetts General Hospital is the lead sponsor of 2,537 studies on the registry; 447 are open to participants now.

Of its 214 completed or terminated interventional studies of FDA-regulated products, 161 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Current permanent employee of Partners Healthcare, Inc. or their adult dependent
  • Current tobacco smoker (smoked a cigarette, even a puff, in the past 30 days)

Exclusion criteria

Exclusion Criteria:

  • Temporary, per diem or former employee of Partners Healthcare, Inc.
  • Plan to leave Partners employment in the next 12 months
  • Inability to give informed consent or participate in counseling due to serious psychiatric disorder or cognitive disorder
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
106 participants (actual)

Study arms

  • Experimental
    Internal coaching program

    The internal coaching program uses a chronic disease management strategy to treat tobacco use and dependence. The program provides evidence-based treatment consisting of up to 12 months of services from a tobacco coach based at Partners HealthCare. The tobacco coach offers (1) repeated smoking cessation counseling delivered by proactive telephone calls, emails, and interactive voice response \[automated phone calls\] and (2) facilitated access to a new Partners HealthCare Inc., health insurance benefit that provides access to all FDA-approved smoking cessation medications without copay or prior approval.

    Behavioral: Internal tobacco coach

  • Active comparator
    External coaching program

    The external coaching program consists of referral to the Massachusetts Tobacco Control Program's Smokers Helpline, a free program offering multi-session proactive telephone counseling for 3 months to individuals who are ready to quit smoking. Individuals in this arm also receive information about Partners HealthCare, Inc.'s new health insurance benefit that provides access to all FDA-approved smoking cessation medications without copay or prior approval.

    Behavioral: External tobacco coach

Interventions

  • BehavioralInternal tobacco coach

    The internal coaching program will provide cognitive-behavioral counseling and medication adherence support for smokers who are ready to quit in the next 3 months It consists of: 1. Telephone counseling by the Tobacco Coach (8 calls over 12 weeks). supplemented by automated phone calls using interactive voice response. At each IVR contact, smokers can request a call back from the Tobacco Coach. Smokers who are not quit after 3 months can restart into the 12-week counseling program. 2. The Tobacco Coach will assist smokers in choosing pharmacotherapy and in obtaining a prescription from the smoker's physician. 3. Support and monitoring for 12 months using automated phone calls. If relapse occurs, the smoker will have the option to return to the active 12-week program.

  • BehavioralExternal tobacco coach

    Referral to Massachusetts Smokers Helpline (telephone quitline operated by the Massachusetts Tobacco Control Program) for proactive telephone counseling.

06

What researchers measure

Primary outcomes

  1. Tobacco abstinence for the past 30 days

    Time frame: 6 months after enrollment

Secondary outcomes

  1. Tobacco abstinence for the past 30 days

    Time frame: 3 months after enrollment

  2. Tobacco abstinence for the past 30 days

    Time frame: 12 months after enrollment

  3. Quit attempt

    Time frame: Intentional tobacco abstinence for at least 24 hours since enrollment

Other outcomes

  1. Duration of use of tobacco cessation pharmacotherapy

    Includes any FDA-approved product (nicotine patch, gum, lozenge, inhaler, nasal spray or bupropion or varenicline

    Time frame: at 3 months and at 6 months after enrollment

  2. Smoking cessation counseling contacts

    Number of telephone calls with an internal or external tobacco coach to address smoking cessation

    Time frame: at 3 months and at 6 months after enrollment

07

Study locations

1 site
  • Massachusetts General Hospital
    Boston, Massachusetts 02114, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 24, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02601521
Lead sponsor
Massachusetts General Hospital
Collaborators
Partners HealthCare, Inc.
Responsible party
Nancy A. Rigotti (Professor of Medicine, Harvard Medical School, Massachusetts General Hospital) — Principal investigator
First posted
Nov 10, 2015
Start date
Nov 2015
Primary completion
Sep 2019
Completion
Mar 2020
Last update
Feb 24, 2021

Study contacts

Nancy A Rigotti, MD
principal investigator · Massachusetts General Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion